Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 8.10
-0.24 (-2.88%)
Sep 9, 2026, 1:20 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 1.09 billion as of September 8, 2026. Its market cap has decreased by -29.97% in one year.
Market Cap
1.09B
Enterprise Value
1.26B
Revenue
1.08B
Ranking
n/a
PE Ratio
24.61
Stock Price
8.10
ChartMarket Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 1.09B, an increase of 279.62%. That is a compound annual growth rate of 16.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 1.09B | -2.90% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 8.30B |
| Amanta Healthcare | 7.68B |
| Bafna Pharmaceuticals | 7.28B |
| Valiant Laboratories | 5.90B |
| Nectar Lifesciences | 2.36B |
| Brooks Laboratories | 1.86B |
| Par Drugs and Chemicals | 1.83B |
| Alpa Laboratories | 1.31B |